Nference leverages advanced artificial intelligence (AI) technologies to transform healthcare data into actionable insights, significantly enhancing clinical research and patient outcomes. Their platform, nSights, is designed to redefine clinical research by enabling the creation of precise patient cohorts, integrated data analysis, and the prediction of biomarkers. It utilizes AI-powered tools to analyze unstructured data, including billions of clinical notes, and employs advanced statistical methods to visualize and compare cohort insights. This comprehensive approach allows researchers to rapidly generate regulatory-grade cohorts and uncover hidden patterns within the data, facilitating a more efficient research process.

The company also emphasizes the importance of patient privacy and regulatory compliance while harnessing diverse data sources. Nference's proprietary algorithms enable the triangulation of insights from electronic medical records (EMR), imaging datasets, and public literature, ensuring high data quality throughout the research lifecycle. Their Imaging Biomarker platform further enhances the analysis of medical images, converting qualitative data into quantitative metrics. By integrating these technologies, Nference aims to democratize real-world data analysis, allowing healthcare systems and life sciences organizations to make informed, evidence-based decisions that drive impactful research and improve patient care.

United States

nference leverages the top academic minds, world-class researchers, and real-time access to multimodal, patient-level data to accelerate drug development innovation, generate evidence, and improve clinical trial processes. nSights, our flagship software platform, delivers the most comprehensive biological and clinical insights into patient care.

Nference

Company Details